If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Find us on

Anergis and Mymetics Start Research Collaboration Project

Mymetics Corporation (OTCQB:MYMX), a pioneer and leader in the research and development of virosome-based vaccines, and Anergis SA, a company developing Contiguous Overlapping Peptides (COPs) for ultra-fast allergy immunotherapy, announced that Mymetics SA, the Swiss subsidiary of Mymetics Corporation and Anergis SA have entered into a Research Collaboration project.

[Exclusif] Découvrez la technologie de la semaine : Hydrogels

Les hydrogels sont des structures en réseau 3D, obtenues à partir de polymères naturels ou...

Les HUG inaugurent un centre à la pointe de la technologie chirurgicale.

Une première en Suisse. Les HUG ont inauguré cette semaine un centre destiné à la...

Ambassadeur de la Health Valley, le suisse Lonza ouvre un centre de bioproduction d’un genre nouveau au Texas

Swiss-based Lonza has just opened the world’s largest dedicated cell-and-gene-therapy manufacturing facility in Pearland, Texas,...

Sanofi fait le tri dans ses portefeuilles OTC et générique

Le groupe pharmaceutique Sanofi vient de vendre douze marques de médicaments sans ordonnance au laboratoire...

Le MedTech Investing Europe Conference se tiendra les 24 et 25 avril prochain, à Lausanne

Chaired by Benoit Dubuis, the 26th MedTech Investing Europe Conference will be held on 24-25...

[Esprit Pionnier] Il y a 75 ans Hofmann découvrait le LSD

Le LSD aura 75 ans lundi. C’est le 16 avril 1943 à Bâle que le...

Intelligence accélérée

Pour croître, se transformer, se réinventer, mettre le feu aux certitudes, l’intelligence doit trouver dans...

L’économie vaudoise au beau fixe

La chimie-pharma, le commerce, les activités immobilières et les services aux entreprises vont bien. Ils...

Shire vend son oncologie à Servier pour 2mds€

Le groupe français Servier a déboursé près de 2 milliards d’euros pour récupérer l’activité oncologie...

eSight veut rendre la vue aux malvoyants

Des lunettes électroniques, qui visent à permettre aux malvoyants de voir sans chirurgie, débarquent en...

Gene Predictis - Tests génétiques pour prévenir les risques liés aux effets adverse

Des tests pour réduire les risques d'effets nocifs liés aux médicaments et à la nutrition. Un article de l'AGEFI

Selexis SA hires new strategic partners to strengthen its cell line development services

Ferring acquires Rebiotix Inc.

Ferring announces their acquisition of Rebiotix Inc., microbiome pioneer.

ADDEX THERAPEUTICS Sucessfully Raises CHF40 million in Capital Increase

"This is a transformational event for Addex which will enable us to advance our portfolio of allosteric modulator drug candidates through important value inflection points, including completing Phase 3 registration studies for dipraglurant," said Tim Dyer, CEO of Addex

MEDTRONIC - Open Innovation Days

Presentation of some of the company’s most advanced manufacturing facilities at Tolochenaz on 3 May 2018

Le Biopôle recrute un/une "Marketing & Communication Manager - 80% “

La personne sélectionnée sera en charge de la stratégie et les actions marcom du Biopôle

Genomic Health: New Real-World Clinical Practice Data

Genomic Health today announced the presentation of new data with the Oncotype DX® test at the 11th European Breast Cancer Conference (EBCC-11) in Barcelona, Spain

MassChallenge 2018 Accelerator Program

Applications are open until 28 March 2018!

Lunaphore collaborates with PerkinElmer

The Swiss start-up announced on 20 March that it will collaborate with the American multinational corporation to develop staining and analysis solutions for tumor samples.

Discover regenHU's 3DDiscovery Evolution bio-printer

regenHU will launch their new product @ the IDTechEX Show on 11-12 April 2018 in Berlin, Germany.

La 2ème édition d’Orthomanufacture

Fort du succès enregistré à St Etienne en juin dernier, Orthomanufacture récidive à Yverdon-les-Bains les 20 et 21 juin 2018.

Lundbeck to acquire Prexton Therapeutics

This acquisition will add foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson's disease
Attachment

Le Challenge Debiopharm Inartis

La qualité de vie du patient en cours de traitement

"Qui pourra changer le monde dans lequel nous vivons?”

Luc Stoppini raconte son Prix BioAlps

Prix BioAlps 2017 : la récompense d’une carrière

Glenmark Pharmaceuticals S.A. to invest in new Translational Research Group @ Biopôle

Glenmark Pharmaceuticals announces it will enhance its capabilities in translational research by opening a new discovery centre at the Biopôle campus of Lausanne.

Kick-off Medtech Accelerator at EPFL Innovation Park

Monday 12 March @ 17:30, at room Neptune, Building C of EPFL Innovation Park

Learn more about La Forge's new expert coaching programs for a selection of verticals.

The first vertical acceleration track will be dedicated for Medtech related projects!

Compugen Has Licensed Selexis' Cell Line-Based Protein Expression Platform for the Development of An

Selexis SA announces that Compugen Ltd. has taken a license to the Selexis SUREtechnology Platform™ for use in generating high-performance research cell banks (RCBs).

Selexis SA and Xencor sign 4 Commercial License Agreements

On 26 February, Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody Drug Candidates

UNIBE - Des cultures cellulaires en 3D contre les résistances des cancers

Business offer from a German company represented by the Enterprise Europe Network

A German company, part of the Enterprise Europe Network, specialized in planning and interior fitting of hospitals and veterinary clinics offers sales representation of its products and services world-wide.

Ferring: 30 million CHF investment in new biotech centre in Switzerland

Ferring expands its capabilities in biologics through a new biotech centre, which will be installed at its global headquarters and manufacturing site in Saint-Prex. The Biotech Centre will incorporate discovery and development capabilities for biologics.

Allergan is seeking new partnerships

Allergan wishes to extend their project portfolio in biopolymers for medical injectable and/or implantable applications through initiating new partnerships with academic or biotech partners.

Fondation BINC-Geneva - Appels à candidatures

Appels à candidatures pour des financements de recherche (académiques) dans les domaines du microbiote, allergie, obésité infantile et dépression postpartum.

Bilan - Les start-up suisses lèvent un milliard en 2017

600 millions de francs d'investissements en 2017 pour les start-ups Medtech et Biotech en Suisse

Quatre plateformes promeuvent l’innovation en Suisse occidentale

Le Journal Entreprise romande nous dévoile les coulisses des quatres plateformes sectorielles de Suisse occidentale

UNRAVELLING THE SECRETS OF THE BRAIN

Bilan and BioAlps special webdoc edition

BioAlps Bridging the World : Worldwide Visibility Package 2018

A yearly international programme for our affiliated companies to increase their visibility
Archive:  2018  2017  2016  2015  2014  2013  2012  2011  2010 
Find an actor

MedTech Investing Europe 2018 (MTi)24.04.2018

The 26th MedTech Investing Europe Conference will be held on 24 and 25 April 2018 at the Royal Savoy Hotel in...

Anergis and Mymetics Start Research Collaboration Project

Mymetics Corporation (OTCQB:MYMX), a pioneer and leader in the research and development of virosome-based vaccines,...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn